Limin Group Raises Prices on Certain Products

On March 17, Liming Co., Ltd. issued a product price adjustment notice stating that recently, due to force majeure, the prices of petrochemical industry chain products, corn starch, and other raw materials have soared, leading to a significant increase in the company’s production costs. The company has decided to raise the prices of Daisen Manganese Zinc raw drugs and related formulations by 10%-15% starting immediately; increase the prices of Abamectin series raw drugs and related formulations by 5%-10%; and raise the prices of other raw drugs and related formulations with larger cost increases by 5%-15%.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin